| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337 |
| filingDate |
2001-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9509a51ac527253dccf6884c6b81e58e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b9b37674c594032481bc277f22e35979 |
| publicationDate |
2003-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2003181473-A1 |
| titleOfInvention |
Farnesyl protein transferase inhibitor combinations with taxane compounds |
| abstract |
The present invention is concerned with combinations of a farnesyl transferase inhibitor and a taxane compound for inhibiting the growth of tumor cells and useful in the treatment of cancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006194821-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007075923-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8232402-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8343996-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2545919-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005272068-A1 |
| priorityDate |
2000-02-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |